4//SEC Filing
O'Byrne Jason 4
Accession 0001628280-25-007703
CIK 0001706431other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 3:41 PM ET
Size
272.4 KB
Accession
0001628280-25-007703
Insider Transaction Report
Form 4
O'Byrne Jason
EVP & Chief Financial Officer
Transactions
- Award
Common Stock
2025-02-22+40,000→ 115,000 total - Award
Stock Option (Right to Buy)
2025-02-22+80,000→ 80,000 totalExercise: $9.57Exp: 2035-02-21→ Common Stock (80,000 underlying)
Footnotes (2)
- [F1]Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan.
- [F2]25% of the shares subject to the stock option vest and become exercisable on February 22, 2026, and the remaining shares vest in 36 equal monthly installments thereafter.
Issuer
Vir Biotechnology, Inc.
CIK 0001706431
Entity typeother
Related Parties
1- filerCIK 0001871145
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 3:41 PM ET
- Size
- 272.4 KB